This Week in Science

In Science this week, an international research team reports the identification of a compound, found in a number of medicines, that appears to regulate a genetic risk factor for Parkinson's disease. In looking for ways to prevent or delay the hallmark accumulation of alpha-synuclein in the brains of Parkinson's patients, the scientists identified beta-2 adrenergic receptor agonists as strong suppressors of alpha-synuclein gene expression.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.